EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

The Role of High-Risk Cytogenetics in Acute Kidney Injury of Newly Diagnosed Multiple Myeloma: A Cohort Study

Carolina Branco iD, Manuel Silva, Natacha Rodrigues, Joana Vieira iD, João Forjaz Lacerda, José António Lopes

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26136108 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Carolina Branco und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Renal Transplantation, Unidade Local de Saúde Santa Maria, 1649-035 Lisbon, Portugal. Hauptthemen laut MEDLINE: Multiple Myeloma, Acute Kidney Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is frequently associated with cytogenetic abnormalities, with high-risk cytogenetics linked to poorer survival. Acute kidney injury (AKI) is common in MM, but its relationship with high-risk cytogenetics remains underexplored. This study aimed to assess the association between high-risk cytogenetics and AKI in newly diagnosed MM patients and to evaluate their impact on overall survival, relapse-free survival, and progression to chronic kidney disease (CKD) in the first two years after diagnosis. We conducted a single-center retrospective cohort study including patients newly diagnosed with MM between 2018 and 2022. We enrolled 122 patients. AKI was observed in 36.9% of patients, rising to 62.3% among those with high-risk cytogenetics. High-risk cytogenetics (OR: 3.32; 95% CI: 1.17–6.40; p = 0.024), CKD (OR: 9.14; 95% CI: 2.92–18.65; p < 0.001), kappa free light chains, hypercalcemia, difference in free light chain (dFLC), and bone marrow plasmocyte percentage were independently associated with AKI. Both AKI (HR: 2.71; 95% CI: 1.18–6.23; p = 0.019) and high-risk cytogenetics (HR: 3.33; 95% CI: 1.13–9.76; p = 0.029) were independently associated with lower overall survival. Among survivors without prior CKD, progression to CKD was higher in those with AKI (30.7% vs. 9.3%; p = 0.041). High-risk cytogenetics were significantly associated with AKI in MM patients. Both factors independently predict worse survival and increased risk of CKD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaAcute Kidney InjuryHumansMaleFemaleAgedMiddle AgedRetrospective StudiesChromosome AberrationsRisk FactorsCytogeneticsRenal Insufficiency, ChronicAged, 80 and overCohort StudiesDisease Progression

Stichwörter der Autor:innen

acute kidney injuryepidemiologyhigh-risk cytogeneticsmultiple myeloma

Autor:innen und Institutionen

  • Division of Nephrology and Renal Transplantation, Unidade Local de Saúde Santa Maria, 1649-035 Lisbon, Portugal.
  • Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal.
  • Division of Hematology, Unidade Local de Saúde Santa Maria, 1649-035 Lisbon, Portugal.
  • Gulbenkian Institute for Molecular Medicine (GIMM), 1649-028 Lisbon, Portugal.

ORCID-Profile: Carolina Branco, Joana Vieira

Zitieren

APA

Branco, C., Silva, M., Rodrigues, N., Vieira, J., Forjaz Lacerda, J., & Lopes, J. A. (2025). The Role of High-Risk Cytogenetics in Acute Kidney Injury of Newly Diagnosed Multiple Myeloma: A Cohort Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136108

Vancouver

Branco C, Silva M, Rodrigues N, Vieira J, Forjaz Lacerda J, Lopes JA. The Role of High-Risk Cytogenetics in Acute Kidney Injury of Newly Diagnosed Multiple Myeloma: A Cohort Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136108

BibTeX
@article{Branco2025,
  author = {Branco, Carolina and Silva, Manuel and Rodrigues, Natacha and Vieira, Joana and Forjaz Lacerda, João and Lopes, José António},
  title = {The Role of High-Risk Cytogenetics in Acute Kidney Injury of Newly Diagnosed Multiple Myeloma: A Cohort Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26136108}
}
Kostenlos starten →